London, United Kingdom–(Newsfile Corp. – October 7, 2025) – Edison issues report on Percheron Therapeutics (ASX: PER) Percheron Therapeutics has reported final results from the Phase I dose escalation study of HMBD-002, its monoclonal antibody targeting VISTA, a novel immune checkpoint protein. The data confirmed the compound’s favourable safety and …
Read More »
Breaking News
- Global Influencers Unite in the Spirit of the Chinese New Year, Co-hosted by Trip.com Group and Tripadvisor China
- China Huace Film & TV Co., Ltd. Announces the Official Release of Historical Television Series Swords Into Plowshares
- Wildbrain Reports Q2 2026 Results
- A City Walk Through Guangzhou: APEC Delegates Gain Insider’s Glimpse into Culture, Tech & Green Development
- Novra Receives US $3.2 Million and a New Loan Agreement Signed with SNAPS
- Lena Skliarova Mordvinova from Perseverance Accelerator to Speak at TechCon Southwest 2026
- CSE Bulletin: Consolidation – Go Metals Corp. (GOCO)
- InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
- Big Gold Closes Upsized Non-Brokered Private Placement
- Medexus Announces Fiscal Q3 2026 Results, Driven by Continued Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection
Matribhumi Samachar
Address : 125 - Rajiv Nagar, Vinayakpur, Kanpur - 208025
Mo. No.: 8303063085
Email: [email protected]
Managed By Y2KSOLUTION
Copyright © Matribhumi Samachar